Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation and Application of Coxsackievirus a6 Virus-Like Particles in Insect Cells

A virus-like, virus-based technology, applied in the field of biomedicine, can solve problems such as the lack of vaccines for hand, foot and mouth disease

Active Publication Date: 2021-09-14
INST PASTEUR OF SHANGHAI CHINESE ACADEMY OF SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is currently no vaccine available against HFMD

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and Application of Coxsackievirus a6 Virus-Like Particles in Insect Cells
  • Preparation and Application of Coxsackievirus a6 Virus-Like Particles in Insect Cells
  • Preparation and Application of Coxsackievirus a6 Virus-Like Particles in Insect Cells

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0111] 1.6 Preparation and purification of VLP

[0112] After the successful expression was verified by a small amount of detection, the P3 generation baculovirus was used for mass expression of VLP. First, insect cells Sf9 (Invitrogen) were infected with P3 generation baculovirus, harvested after 72 hours and centrifuged to separate the medium from the cells, and the precipitated cells were lysed and broken with Tris-Nacl buffer containing 1% NP-40 to obtain the lysed The solution was concentrated by ultracentrifugation on a 20% sucrose pad at 27,000 rpm for 6 hours, and the resulting precipitate was resuspended with Tris-Nacl. Then, through 10%-50% sucrose density gradient centrifugation, the condition is 39,000 rpm, 2.5h, after sucrose density gradient centrifugation, 12 fractions of equal volume are taken from top to bottom to analyze the VLP content. The VLP-rich fractions were collected and mixed, and then concentrated by ultracentrifugation on a 20% sucrose pad, the co...

Embodiment 1

[0133] Expression of embodiment 1CA6-VLP

[0134] In order to be able to co-express the P1 and 3CD proteins of CA6, the inventors inserted the P1 and 3CD coding polynucleotide sequences together into the pFBD vector, and the P1 and 3CD were respectively located behind the pPH and pP10 promoters to obtain pFBD-CA6-P1 / 3CD , whose structure is shown in the figure 1 As shown in A. This plasmid was then used to transform DH10Bac TM Competent cells obtain Bac-CA6-P1 / 3CD for subsequent expression. The present inventor adopts Bac-to-Bac insect baculovirus expression system, transfects Sf9 cell with Bac-CA6-P1 / 3CD, uses the Sf9 cell of untransfected plasmid as control, uses indirect ELISA ( figure 1 B) and Western Blot ( figure 1 C) detection of the expression of CA6-P1 / 3CD, anti-CA6-VP0, anti-CA6-VP1 and anti-CA6-VP3 three kinds of antibody detection all show that the cell lysate of transfection Bac-CA6-P1 / 3CD can produce very strong Specific reaction, while the Sf9 cells not tra...

Embodiment 2

[0135] Assembly and antigenic identification of embodiment 2CA6-VLP

[0136] In order to identify the expression and assembly of CA6-VLP, Bac-CA6-P1 / 3CD transfected Sf9 and blank Sf9 cell lysates were subjected to 10%-50% sucrose density gradient centrifugation after being passed through a 20% sucrose pad, from top to bottom Take 12 layers, and use indirect ELISA and Western Blot to detect the protein content of each layer. The results of ELISA analysis showed that there were more VPO, VP1 and VP3 proteins in layers #6, #7 and #8 ( figure 2 A). The results of Western Blot detection also showed that anti-CA6-VP0, VP1 and VP3 were used as antibodies, and strong specific reactions could be produced in these three layers ( figure 2 B). The layers rich in VLP were collected and mixed, and then concentrated as a 20% sucrose cushion to obtain a CA6-VLP vaccine with better purity and higher concentration. Get this solution and analyze with transmission electron microscope, can o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides the preparation and application of Coxsackievirus A6 virus-like particles in insect cells. Specifically, the present invention obtains a method for preparing Coxsackie A6 virus-like particles through extensive and in-depth research. In the method Using codon-optimized Coxsackie A6 virus P1 protein and 3CD protein coding sequences, expressed in insect cells, can be automatically assembled to form VLP, and the expression level is high, easy to purify, and the purified VLP has strong immunogenicity .

Description

technical field [0001] 本发明属于生物医药领域,具体地说,本发明涉及柯萨奇病毒A6病毒样颗粒在昆虫细胞中的制备及其应用 Background technique [0002] 手足口病是一种接触性传播疾病,广泛流行于亚太平洋地区。主要感染五岁以下儿童引起发热,手、足、口和臀部疱疹,以及咳嗽等症状,少数患儿可在短期内出现严重神经症状和心肺系统并发症,甚至死亡。但是,目前还没有针对手足口病的可用疫苗。 [0003] 自2008年,肠道病毒71型(EV71)和柯萨奇病毒16型(CA16)因其广泛传播流行成为手足口病的两个主要病原,疫苗的研究开发也多针对该两种病毒。然而,最近几年,关于柯萨奇CA6引起的手足口病全球流行,尤其是亚洲和欧洲地区流行的报道不断增多,吸引了广泛的关注。柯萨奇CA6病毒感染可以引起发热、疱疹等典型手足口病症状,同时伴有疱疹爆发处溃疡、结痂以及脱甲等非典型手足口病症状,并且不仅可感染幼年儿童也可对成年人造成严重伤害。最近有研究报道揭示柯萨奇CA6病毒颗粒的衣壳蛋白组成,并证明非结构蛋白区域(2A-3D)的变化是导致该病毒感染引起非典型手足口病症状的重要原因。 [0004] 以中国某些省市的临床研究报告为例,2013年,广东省60.3%的手足口病爆发是由于柯萨奇CA6病毒感染引起,吉林长春爆发的手足口病案例中66.9%也由该病毒 lead to. 这些临床研究报告显示了柯萨奇CA6的流行越来越广泛,逐渐成为手足口病爆发的主要病原之一,而且,免疫了EV71或CA16疫苗的人群仍然可以被柯萨奇CA6病毒感染,所以针对柯萨奇CA6的疫苗开发十分必要,也能为以后双价或多价疫苗的研究和发展作铺垫。 [0005] 因此,为了有效地、有针对性地预防柯萨奇CA6感染,本领域迫切需要开发针对柯萨奇CA6的疫苗及其应用。 Contents of the invention [0006] 本发明的目的在于提供一种在昆虫细胞中制备的柯萨奇病毒A6病毒样颗粒、其制备方法及其应用。 [0007] 本发明的第一方面,提供了一种分离的经密码子优化的多核苷酸,所述多核苷酸编码柯萨奇A6病毒P1蛋白;并且所述多核苷酸选自下组: [0008] (a)序列如SEQ ID NO.3所示的多核苷酸; [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/41C12N15/866C12N7/04A61K39/125A61P31/14
CPCA61K39/12A61K2039/5258C07K14/005C12N7/00C12N15/86C12N2770/32022C12N2770/32023C12N2770/32034C12N2770/32143
Inventor 黄忠沈超云刘庆伟张伟
Owner INST PASTEUR OF SHANGHAI CHINESE ACADEMY OF SCI